US Bancorp’s Cogentix Medical, Inc. CGNT Stock Holding History

US Bancorp’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,906	Closed	-$11K	–	3792
2018 Q1	$11K	Hold	2,906	–	–	﹤0.01%	3137
2017 Q4	$9K	Hold	2,906	–	–	﹤0.01%	3191
2017 Q3	$7K	Hold	2,906	–	–	﹤0.01%	3190
2017 Q2	$5K	Hold	2,906	–	–	﹤0.01%	3254
2017 Q1	$5K	Buy	+2,906	New	+$5.74K	﹤0.01%	3231

US Bancorp's CGNT Position: Q2 2018 in Review

US Bancorp sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 2,906 shares — an estimated $11K sold.

US Bancorp first reported a position in CGNT in Q1 2017 and held it in 5 quarters. The position peaked at $11K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

US Bancorp reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
US Bancorp sold 2,906 Cogentix Medical, Inc. shares in Q2 2018, an estimated $11K.
US Bancorp first reported a position in Cogentix Medical, Inc. in Q1 2017 and held it in 5 quarters.
US Bancorp's Cogentix Medical, Inc. position peaked at $11K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on US Bancorp's 13F filing for Q2 2018, filed 8 Aug 2018.